Offering clinical trials is paramount, explained Bradley Prechtl, MBA, chief executive officer of Florida Cancer Specialists and the American Oncology Network.
Offering clinical trials is paramount, explained Bradley Prechtl, MBA, chief executive officer of Florida Cancer Specialists and the American Oncology Network.
Transcript
In addition to offering patients the best available treatments, how important is it for oncology practices to offer clinical trials?
I think offering clinical trials is paramount. It’s kind of interesting because I’ve been in healthcare almost 30 years, but I think clinical research is crucial when it comes to medical oncology and I think practices that don’t offer clinical research as a part of their offering, quite frankly, I think isn’t first of mind for the physicians who are taking care of medical oncology patients. So, having the ability to offer clinical research trials for patients that aren’t progressing well with standard of care is just giving the patient the best fighting chance.
It’s been a huge differentiator for us, especially in Florida, because we compete with 3 academic medical centers who have clinical research. Being able to offer clinical research in the community setting is a phenomenal benefit to patients.
Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care
February 25th 2025On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
Listen
Texas Oncology to Roll Out Canopy for ePROs After Head-to-Head Pilot
March 18th 2025Debra Patt, MD, PhD, MBA, executive vice president of Public Policy and Strategy for Texas Oncology, said the practice received positive feedback from nurses and patients during a pilot that concluded in February.
Read More